PD 166285 dihydrochloride is a WEE1 inhibitor with weak inhibitory activity against Myt1 (IC50 = 24 nM and 72 nM, respectively) and also exhibits inhibitory activity against Chk1 (IC50 = 3.433 μM). It functions as a radiosensitizer, enhancing radiation-induced cell death in various cancer cell lines, particularly in p53-mutant or p53-null cells. It abrogates radiation-induced G2 arrest and increases mitotic cell populations. Additionally, it dramatically inhibits irradiation-induced Cdc2 phosphorylation at Tyr-15 and Thr-14. In vivo, it shows limited brain penetration due to P-glycoprotein (P-gp) efflux.